Loading...

Onconetix, Inc.

ONCONASDAQ
Healthcare
Biotechnology
$0.73
$0.05(7.52%)
U.S. Market is Open • 09:34

Onconetix, Inc. (ONCO) Stock Overview

Explore Onconetix, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.5M
P/E Ratio-0.16
EPS (TTM)$-82.80
ROE-1.90%
Fundamental Analysis

AI Price Forecasts

1 Month$3.01
3 Months$5.00
1 Year Target$0.00

ONCO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Onconetix, Inc. (ONCO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.16 and a market capitalization of 2.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.52%
5-Day Change
-4.29%
1-Month Change
-76.53%
3-Month Change
-91.07%
6-Month Change
-95.76%
Year-to-Date (YTD) Change
-90.67%
1-Year Change
-97.12%
3-Year Change
-100.00%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

513 620 4101
201 East Fifth Street, Cincinnati, OH, 45202

Company Facts

12 Employees
IPO DateFeb 18, 2022
CountryUS
Actively Trading

Frequently Asked Questions